Singapore OTC Drugs Market

Singapore Over Counter Drugs Market Size (2024 to 2032)

The size of the Over Counter Drugs Market in Singapore was worth USD 692.88 million in 2024 and estimated to reach USD 1004.08 million by the end of 2032 with a growing potential of 5.45%.

Singapore is placed in fourth place, given its excellent political and economic outlook by Business Environment Rankings for Asia. Singapore OTC Pharmaceuticals market accounts for 1.2% of the total Asia-Pacific OTC market.

The term Over the Counter (OTC) refers to pharmaceuticals bought across the counter without any prescription from physicians. Consumers in Singapore are gradually increasing to take the route of self-medication due to growing pressure on healthcare budgets. Together with the Reducing output from drug manufacturing Companies, R&D efforts have led to a better focus on advancing innovative over-the-counter and consumer health drugs. With the rising aged population and middle class, it is not astonishing that over-the-counter is one of the fastest-growing segments in Singapore. The growth of the aging population (>65) is increasing rapidly and will accounts for 19% of the population in Singapore by 2030. Demand for OTC drugs is growing as patients are taking a proactive approach in treating ailments.

Increasing pressure from consumers, drug regulators, and manufacturers to renovate prescription medications to Over-the-Counter (OTC) non-prescription status are the major drivers for the growth of the OTC drugs market. Cost-aware insurance programs will drive the market even further by encouraging customers to self-treatment regarding chronic conditions by providing increased incentives for the newly approved OTC medicines.

Cost sensitivity of production and very high competition among the key players are the major factors restraining the growth of the market.

This research report is segmented & sub-segmented the Singapore OTC Drugs Market into the following categories.

• By Formulation Type                              
  • Tablets      
  • Liquids      
  • Ointments               
  • Sprays       
• By Product Type                       
  • Cough, Cold, and Flu Drugs
  • Analgesics
  • Dermatologicals    
  • Gastrointestinal Drugs
  • Antiseptics              
  • Anti-Allergy Drugs
  • Smoking Cessation Aids     
  • Ophthalmic Drugs
  • Vitamins and Minerals       
  • Sleep Aids             
  • Weight Loss/Diet Products            
  • Others (Ear Drops & Diuretics)     
• By Distribution Channel                         
  • Pharmacies/Drugstores     
  • Supermarkets/Hypermarkets         
  • Convenience stores            
  • Others (Online Drugstores)

KEY MARKET PLAYERS

Some of the key players dominating the Over the Counter Drugs market in Singapore are Eu Yan Sang International Ltd, Bayer AG, Johnson & Johnson, Glaxo SmithKline PLC, Merck Pte Ltd, Sunward Pharmaceutical Pte Ltd, Beacons Pharmaceuticals (Pte) Ltd.